Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues
1Instituto de Investigaciones Citológicas, Amadeo de Saboya 4, 46010, Valencia, Spain.
Abstract:
PTEN, a tumour suppressor gene located at chromosome 10q23 and commonly mutated or deleted in a variety of tumours, encodes a dual-specific/phosphatidylinositol-3,4,5-triphosphate (PIP3) phosphatase. We report the generation of an anti-PTEN monoclonal antibody (MAb) that recognises an epitope at the C-terminus of PTEN, and describe the heterogeneous lack of expression of the PTEN protein in human tumour tissues, as demonstrated by immunohistochemical methods. Our anti-PTEN MAb provides a useful tool for the study of PTEN protein expression in tumour samples, in the search for tumour prognostic molecular markers.
Insights
Researchers developed a new antibody to detect the PTEN protein, a tumor suppressor. This tool reveals varied PTEN expression in human tumors, aiding in the search for prognostic markers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- PTEN is a crucial tumor suppressor gene located at chromosome 10q23.
- PTEN mutations or deletions are frequent in various human cancers.
- PTEN encodes a phosphatase enzyme critical for regulating cellular processes.
Purpose of the Study:
- To generate a monoclonal antibody (MAb) targeting the PTEN protein.
- To investigate the expression patterns of PTEN protein in human tumor tissues.
- To evaluate the utility of the anti-PTEN MAb as a tool for cancer research.
Main Methods:
- Generation of a monoclonal antibody specific to the C-terminus of PTEN.
- Immunohistochemical analysis of human tumor samples to assess PTEN protein expression.
- Characterization of PTEN expression heterogeneity in different tumor types.
Main Results:
- Successful generation of an anti-PTEN monoclonal antibody.
- Demonstration of heterogeneous PTEN protein expression in human tumor tissues.
- Identification of varied PTEN protein loss in various cancers.
Conclusions:
- The developed anti-PTEN MAb is a valuable tool for studying PTEN protein expression in tumors.
- Assessing PTEN expression may serve as a prognostic molecular marker in oncology.
- Further research can utilize this antibody to explore PTEN's role in tumorigenesis and patient outcomes.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


